Status:

UNKNOWN

Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Sars-CoV2

Eligibility:

All Genders

18+ years

Brief Summary

SARS-CoV-2 induced by COVID 19, involved the hospitalization of 101,932 patients in France, including 4,007 in intensive care (source: Santé Publique France). Alsace was one of the most affected regio...

Eligibility Criteria

Inclusion

  • Criteria for inclusion :
  • Major patient (≥18 years old)
  • Patient hospitalized in intensive care at the NHC, diagnosed COVID + and requiring a VD session of which at least one is performed by the dedicated team.
  • patient who has not expressed, after information, his or her opposition to the re-use of his or her data for the purposes of this research
  • Exclusion criteria :
  • Subject who expressed opposition to participating in the study
  • Subject under guardianship, curatorship or safeguarding of justice

Exclusion

    Key Trial Info

    Start Date :

    March 25 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 20 2020

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT04438941

    Start Date

    March 25 2020

    End Date

    June 20 2020

    Last Update

    June 23 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil

    Strasbourg, France, 67091